COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Li-Metal Provides Update on Next-Generation Battery Technologies in Partnership with the Ontario Government
Li-Metal Corp. and Lyten are partnering with the Ontario government through the Ontario Vehicle Innovation Network (OVIN) to develop specialty lithium alloy ingots for next-generation lithium metal anodes. The partnership aims to contribute to the growth of the province's end-to-end auto and EV battery supply chain, with support from OVIN. The collaboration is expected to further advance the development of sustainable lithium metal production capacity and specialty ingots, ultimately strengthening Ontario's battery production capabilities and accelerating the shift to electrification. -
COMMUNIQUÉ DE PRESSE
Fury Intercepts 31.77 g/t gold and 8.07 g/t Tellurium over 3.5 metres at the Hinge Target
Fury Gold Mines Limited (TSX:FURY)(NYSE American:FURY) is excited to announce the fourth set of results from the 2023 drilling program at the Hinge Target, showcasing multiple stacked zones of gold-mineralized quartz tourmaline veins. These impressive results have increased confidence in the geological model and potential for expansion of the Eau Claire resource to the west, with additional results still pending. CEO Tim Clark anticipates the inclusion of these results in the Eau Claire mineral resource update expected to be released at the end of Q1 or early Q2. -
-
COMMUNIQUÉ DE PRESSE
Guanajuato Silver Commences Processing 3rd Party Gold and Silver at El Cubo
Guanajuato Silver Company Ltd. announces a new relationship with a Mexican silver mining company to process a portion of its surface inventory of mineralized material at Guanajuato Silver's El Cubo mines complex. This processing agreement is expected to generate the first silver and gold concentrates by the end of January 2024. Guanajuato Silver is a rapidly growing silver producer in Mexico, with four operating mines and three processing facilities. -
COMMUNIQUÉ DE PRESSE
UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review
UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com. -
COMMUNIQUÉ DE PRESSE
Bioz and Innovative Research Forge a Dynamic Partnership to Advance Research Excellence
Bioz, Inc., a leading Silicon Valley-based AI software company, partners with Innovative Research to provide real-time product application data through interactive digital web widgets called Bioz Badges, displaying structured information from journal publications. This partnership aims to benefit researchers by efficiently reviewing publication data for greater product validation. -
COMMUNIQUÉ DE PRESSE
Coppernico Appoints Keenan Jennings as a Board Director
Coppernico Metals Inc. has appointed Mr. Keenan Jennings, MBA, MSc., as a Board Director effective January 13, 2024. Mr. Jennings brings over 35 years of experience in global mineral exploration and has a successful track record in the mining industry. The Company has also closed on a third tranche of its non-brokered private placement, with directors, including Mr. Jennings, participating. For further information on Coppernico, please visit www.coppernicometals.com. -
COMMUNIQUÉ DE PRESSE
Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling
Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. -
COMMUNIQUÉ DE PRESSE
Griffin Mining Limited Announces Fourth Quarter & Full Year Production 2023
Griffin Mining Limited announces record production results from the Caijiaying Zinc Gold Mine for the fourth quarter and full year 2023. The production saw significant increases in ore mined, ore processed, zinc, gold, silver, and lead production. The company achieved extraordinary results in 2023 and experienced a rise in market prices for zinc, gold, silver, and lead in the last quarter of 2023. Mladen Ninkov, Chairman, expressed his pride and acknowledged the exceptional achievement of the management and staff. Griffin Mining Limited operates the Caijiaying Zinc Gold Mine in China, producing zinc, gold, silver, and lead metals in concentrates.
